Business Models

Maximize New Product Potential Through Early Commercial Planning

November 15, 2019

Pharmaceutical Executive

Five key areas biopharma manufacturers focus on to predict where the markets will be and determine how standards of care will evolve to effectively position new products.

Leading Integration: Six Steps to Preserve Acquisition Value

October 31, 2019

Healthy companies with coherent integration strategies will benefit from applying six lessons to ensure successful integration, writes Mark Bouch.

Lay the Tech Foundation for IPO Success

October 18, 2019

Mike Kean and Billy Tamulynas discuss the key components of growth-ready technology for early-stage pharma companies and how to make optimal use of them.

Olivier Laureau, Servier: Free to Grow, Innovate

October 09, 2019

Pharmaceutical Executive

French independent pharma Servier Group, led by president Olivier Laureau, is uniquely positioned to capitalize on new opportunities for expansion and stay true to its R&D and patient-focused mission.

Commercialization Imperatives for Success in Rare Diseases

September 13, 2019

To ensure patients have timely access to expensive new therapies, biopharma companies have to address commercialization challenges with innovative measures, even after getting regulatory approval.

The Synergistic Organization

August 23, 2019

A key question for an organization post-M&A is: “What organizational capabilities support global guidance and leadership, and which of them require these at the 'local' level?” Scott Hull discusses potential solutions.

Luxturna: A Vision for Curative Therapy Access

August 08, 2019

Pharmaceutical Executive

Pharm Exec highlights a recent fireside chat between Veeva’s Matt Wallach and Jeffrey Marrazzo, CEO of Luxturna maker Spark Therapeutics.

Shared Understanding Creates Culture

July 08, 2019

While culture may "eat" strategy, shared understanding creates both culture and strategy, write Steve Figman and Sean Robertson.

Pharma Medical Affairs: A Blueprint for Future

June 24, 2019

Pharmaceutical Executive

Changing customer preferences and a growing need for specialized knowledge are challenging the traditional scope of the medical affairs function. Learn about six ways pharma MA departments can drive more collaborative relationships with caregivers.

'Vision’ Quest: Leading Through Change

June 21, 2019

Pharmaceutical Executive

Exploring the critical go-to strategies for biopharma C-suite executives in navigating organizational disruption and the impact of global change and volatility on their employees and business.